89bio Inc (ETNB)
8.92
+0.02
(+0.22%)
USD |
NASDAQ |
Nov 27, 11:31
89bio Shares Outstanding: 117.58M for Nov. 18, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
November 18, 2024 | 117.58M |
November 14, 2024 | 117.58M |
October 31, 2024 | 106.13M |
September 30, 2024 | 106.13M |
July 29, 2024 | 105.91M |
June 30, 2024 | 104.92M |
May 06, 2024 | 98.38M |
April 04, 2024 | 95.22M |
April 01, 2024 | 95.22M |
March 31, 2024 | 95.20M |
February 21, 2024 | 93.50M |
December 31, 2023 | 93.27M |
December 11, 2023 | 93.21M |
November 06, 2023 | 75.64M |
September 30, 2023 | 75.64M |
July 31, 2023 | 75.48M |
June 30, 2023 | 75.47M |
May 02, 2023 | 72.87M |
April 06, 2023 | 72.87M |
April 01, 2023 | 72.82M |
March 31, 2023 | 72.87M |
March 29, 2023 | 70.06M |
March 28, 2023 | 69.15M |
March 03, 2023 | 52.23M |
December 31, 2022 | 50.56M |
Date | Value |
---|---|
November 07, 2022 | 46.54M |
October 19, 2022 | 46.48M |
September 30, 2022 | 43.62M |
August 05, 2022 | 39.07M |
July 01, 2022 | 39.03M |
June 30, 2022 | 20.37M |
May 02, 2022 | 20.35M |
April 07, 2022 | 20.35M |
April 01, 2022 | 20.35M |
March 31, 2022 | 20.35M |
March 01, 2022 | 20.35M |
December 31, 2021 | 20.32M |
November 08, 2021 | 20.28M |
September 30, 2021 | 20.10M |
August 06, 2021 | 20.09M |
June 30, 2021 | 20.08M |
May 07, 2021 | 20.06M |
April 08, 2021 | 20.03M |
April 01, 2021 | 20.03M |
March 31, 2021 | 20.03M |
March 01, 2021 | 19.95M |
December 31, 2020 | 19.93M |
November 06, 2020 | 19.88M |
September 30, 2020 | 19.88M |
September 23, 2020 | 20.37M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
13.79M
Minimum
Dec 12 2019
117.58M
Maximum
Nov 14 2024
47.15M
Average
20.37M
Median
Jun 30 2022
Shares Outstanding Benchmarks
Madrigal Pharmaceuticals Inc | 21.81M |
Eli Lilly and Co | 949.32M |
Viking Therapeutics Inc | 111.44M |
Akero Therapeutics Inc | 69.80M |
NovaBay Pharmaceuticals Inc | 4.886M |